These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17487467)

  • 1. [Exacerbation of a schizoaffective psychosis after in vitro fertilization with leuproreline acetate].
    Abu-Tair F; Strowitzki T; Bergemann N
    Nervenarzt; 2007 Jun; 78(6):691-2, 694-5. PubMed ID: 17487467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cycles.
    Meyer L; Murphy LA; Gumer A; Reichman DE; Rosenwaks Z; Cholst IN
    Fertil Steril; 2015 Sep; 104(3):637-42. PubMed ID: 26149355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
    Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
    Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune thyroiditis during leuprolide acetate treatment.
    Eyal O; Rose SR
    J Pediatr; 2004 Mar; 144(3):394-6. PubMed ID: 15001954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient psychosis in women on clomiphene, bromocriptine, domperidone and related endocrine drugs.
    Seeman MV
    Gynecol Endocrinol; 2015 Oct; 31(10):751-4. PubMed ID: 26291819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian stimulation for in vitro fertilization in patients with endometriosis.
    Zikopoulos K; Kolibianakis EM; Devroey P
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):651-5. PubMed ID: 15225190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin releasing hormone agonist and levonorgestrel-intrauterine device followed by in vitro fertilization program as management strategy for an infertile endometrial cancer patient: a case report.
    Nucera G; Mandato VD; Gelli MC; Palomba S; La Sala GB
    Gynecol Endocrinol; 2013 Mar; 29(3):219-21. PubMed ID: 23153053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles.
    Seval MM; Özmen B; Atabekoğlu C; Şükür YE; Şimşir C; Kan Ö; Sönmezer M
    J Obstet Gynaecol Res; 2016 Sep; 42(9):1146-51. PubMed ID: 27199084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone agonist trigger in clinical in vitro fertilization: can the suboptimal candidate be defined?
    O'Neill KE; Coutifaris C
    Fertil Steril; 2015 Sep; 104(3):555-6. PubMed ID: 26253818
    [No Abstract]   [Full Text] [Related]  

  • 11. Leuprolide acetate reduces both in vivo and in vitro ovarian steroidogenesis in infertile women undergoing assisted reproduction.
    Silva AL; Abreu LG; Rosa-e-Silva AC; Ferriani RA; Silva-de-Sá MF
    Steroids; 2008 Dec; 73(14):1475-84. PubMed ID: 18789958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of recombinant follicle-stimulating hormone on bone turnover markers in infertile women undergoing in vitro fertilization procedure.
    Omodei U; Mazziotti G; Donarini G; Gola M; Guella V; Pagani F; Bugari G; Porcelli T; Giustina A
    J Clin Endocrinol Metab; 2013 Jan; 98(1):330-6. PubMed ID: 23093489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
    Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
    Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cycles triggered with GnRH agonist: exploring low-dose HCG for luteal support.
    Castillo JC; Dolz M; Bienvenido E; Abad L; Casañ EM; Bonilla-Musoles F
    Reprod Biomed Online; 2010 Feb; 20(2):175-81. PubMed ID: 20113955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical comparison of ovarian stimulation and luteal support agents in patients undergoing GnRH antagonist IVF cycles.
    Miller CE; Zbella E; Webster BW; Doody KJ; Bush MR; Collins MG
    J Reprod Med; 2013; 58(3-4):153-60. PubMed ID: 23539885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified super-long down-regulation protocol improved the outcome of in vitro fertilization-embryo transfer in infertile patients.
    Gong F; Tang Y; Zhang H; Lu G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 34(3):185-9. PubMed ID: 19349670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal outcome of pregnancies after inadvertent exposure to gonadotrophin-releasing hormone analogue.
    Tan HH; Yeong CT; Loh KE
    Aust N Z J Obstet Gynaecol; 2006 Aug; 46(4):336-40. PubMed ID: 16866796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes to Schizophrenia Spectrum and other psychotic disorders in DSM-5].
    Schultze-Lutter F; Schimmelmann BG
    Z Kinder Jugendpsychiatr Psychother; 2014 May; 42(3):193-202. PubMed ID: 24846868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.
    Griffin D; Feinn R; Engmann L; Nulsen J; Budinetz T; Benadiva C
    Fertil Steril; 2014 Aug; 102(2):405-9. PubMed ID: 24842671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.